492 related articles for article (PubMed ID: 15964643)
21. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
[TBL] [Abstract][Full Text] [Related]
22. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.
Letsas KP; Weber R; Bürkle G; Mihas CC; Minners J; Kalusche D; Arentz T
Europace; 2009 Feb; 11(2):158-63. PubMed ID: 19010799
[TBL] [Abstract][Full Text] [Related]
23. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation.
Henningsen KM; Nilsson B; Bruunsgaard H; Chen X; Pedersen BK; Svendsen JH
Scand Cardiovasc J; 2009; 43(5):285-91. PubMed ID: 19117239
[TBL] [Abstract][Full Text] [Related]
25. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of inflammatory and oxidative markers following the successful cardioversion of persistent lone atrial fibrillation.
Leftheriotis DI; Fountoulaki KT; Flevari PG; Parissis JT; Panou FK; Andreadou IT; Venetsanou KS; Iliodromitis EK; Kremastinos DT
Int J Cardiol; 2009 Jul; 135(3):361-9. PubMed ID: 18640731
[TBL] [Abstract][Full Text] [Related]
27. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
[TBL] [Abstract][Full Text] [Related]
28. Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
Fujiki A; Sakamoto T; Nishida K; Mizumaki K; Inoue H
J Cardiovasc Pharmacol; 2007 Sep; 50(3):264-6. PubMed ID: 17878753
[TBL] [Abstract][Full Text] [Related]
29. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
[TBL] [Abstract][Full Text] [Related]
30. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Smith P; Arnesen H
Am J Cardiol; 2007 Jun; 99(11):1544-8. PubMed ID: 17531578
[TBL] [Abstract][Full Text] [Related]
31. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.
Rizos I; Rigopoulos AG; Kalogeropoulos AS; Tsiodras S; Dragomanovits S; Sakadakis EA; Faviou E; Kremastinos DT
J Hum Hypertens; 2010 Jul; 24(7):447-57. PubMed ID: 20072146
[TBL] [Abstract][Full Text] [Related]
32. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
33. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
Naji F; Suran D; Kanic V; Vokac D; Sabovic M
Med Sci Monit; 2009 Sep; 15(9):CR494-8. PubMed ID: 19721402
[TBL] [Abstract][Full Text] [Related]
34. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
Wozakowska-Kaplon B; Bartkowiak R; Janiszewska G
Pacing Clin Electrophysiol; 2010 May; 33(5):561-5. PubMed ID: 20059712
[TBL] [Abstract][Full Text] [Related]
35. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
Ozaydın M; Erdoğan D; Tayyar S; Uysal BA; Doğan A; Içli A; Ozkan E; Varol E; Türker Y; Arslan A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):305-9. PubMed ID: 21543294
[TBL] [Abstract][Full Text] [Related]
36. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
[TBL] [Abstract][Full Text] [Related]
37. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
38. Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation.
Climent V; Marín F; Mainar L; Roldán V; García A; Martínez JG; Lip GY
Int J Cardiol; 2009 Feb; 132(2):227-32. PubMed ID: 18234374
[TBL] [Abstract][Full Text] [Related]
39. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.
Zohar P; Kovacic M; Brezocnik M; Podbregar M
Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117
[TBL] [Abstract][Full Text] [Related]
40. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
